Dr. Qin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-633-5555Fax+1 214-645-6757
Summary
- Dr. Qin is originally from Houston, Texas. She earned her undergraduate degree in Biological Sciences and Asian Studies at Rice University and earned her medical degree at Baylor College of Medicine. She completed her residency in internal medicine at Houston Methodist Hospital and gained advanced training through a hematology and medical oncology fellowship at the Icahn School of Medicine at Mount Sinai.
Dr. Qin has a strong background in genitourinary malignancies. Her specialization includes kidney, prostate, bladder, and testicular cancers. Her research interests include novel biomarkers, therapeutics, and therapeutic combinations in genitourinary cancers, particularly in the context of clinical trials. Her clinical practice emphasizes a team-oriented and comprehensive approach to patient care. She hopes to guide patients as a partner and an advocate in their treatment journey.
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2018 - 2021
- Methodist Hospital (Houston)Residency, Internal Medicine, 2015 - 2018
- Baylor College of MedicineClass of 2015, MD
- Rice UniversityBA, Biological Sciences and Asian Studies, 2007 - 2011
Certifications & Licensure
- TX State Medical License 2021 - 2026
- NY State Medical License 2018 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsPathological Response and Outcomes in Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Immunotherapy-Based Therapies and Undergoing Deferred Cytoreductiv...Damla Gunenc, Wadih Issa, Thomas Gerald, Qinhan Zhou, Song Zhang
Clinical Genitourinary Cancer. 2024-10-01 - 1 citationsGenitourinary cancers updates: highlights from ASCO 2023.Qian Qin, Hollie Sheffield, Sean M Taasan, Andrew Z Wang, Tian Zhang
Journal of Hematology & Oncology. 2023-11-21 - 1 citationsToxicity Management of Systemic Kidney Cancer Therapies.Qian Qin, Ellen Nein, Andrea Flaten, Tian Zhang
Hematology/oncology Clinics of North America. 2023-10-01
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: